New diabetes clinical trial: Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Published on: January 07, 2025 at 11:00PM
Conditions: Metabolic Associated Fatty Liver Disease; Metabolic Associated-dysfunction Steatohepatitis (MASH); Obesity
Interventions: Drug: semaglutide; Other: Diet
Sponsors: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Not yet recruiting
https://ift.tt/wy6lYkd
Conditions: Metabolic Associated Fatty Liver Disease; Metabolic Associated-dysfunction Steatohepatitis (MASH); Obesity
Interventions: Drug: semaglutide; Other: Diet
Sponsors: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Not yet recruiting
https://ift.tt/wy6lYkd
Comments
Post a Comment